United States, Rockville MD, Aug. 17, 2022 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast biopsy marker market is estimated at US$ 798 million in 2022 and is expected to expand at an impressive CAGR of 5.8% through the forecast years of 2022-2032.
Breast biopsy markers are integrated into the biopsy procedure as they offer the advantage of identifying and marking of the biopsy area with a marker (also called a clip), which helps surgeons in the diagnostic process. Key players are concentrating on delivering quality and standardised products with respect to patients' safety while considering government norms and the safety requirements of providers. Breast biopsy markers will become more popular in the market as a result of assured product quality and reduced dangers.
For Critical Insights on Breast Biopsy Marker Market, Request a Sample Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=7619
Use of breast biopsy markers have increased significantly in the early detection of breast cancer due to initiatives taken by governments and various other organizations for breast cancer screening. Breast biopsy markers are associated with no pain and disfigurement to the body as compared to open surgery, which, is why they are highly acceptable by end users and patients.
Why is There Healthy Demand Growth for Breast Biopsy Markers?
“Rising Incidence of Breast Cancer Driving Sales of Breast Biopsy Markers”
Breast cancer is known to be amongst the most prevalent anomaly worldwide. According to the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths among the population. It was observed that, in the year 2018, over 265,000 new cases of breast cancer were detected among women and one in every eight women was likely to be diagnosed with breast carcinoma.
Breast biopsy markers are used in the biopsy process that offers the advantage of identifying and marking the biopsy area with a physical tag that helps the surgeon in the diagnosis and operating process. Therefore, a rise in the number of breast cancer patients across the world is likely to uplift the breast biopsy marker market in parallel.
To learn more about Breast Biopsy Marker Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7619
Key Segments Covered in the Breast Biopsy Marker Industry Survey
- By Coating Type :
- With Bio-Absorbable Coating
- Without Coating
- With Bio-Absorbable Coating
- By Material :
- Metals & Alloys
- Titanium
- Stainless Steel
- Nitinol
- Nickel-Chromium
- Others
- Non-Metals
- Carbon-coated Ceramic
- Carbon-coated Zirconium Oxide
- PEKK
- Metals & Alloys
- By Provider :
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Hospitals
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & ASEAN
- Oceania
- MEA
- North America
Market Development
Despite challenging economic conditions, the business environment in the breast biopsy marker market still reflects highly positive growth. Market leaders such as Hologic, Carbon Medical Technology, BD, and Argon Medical Devices are competing for market domination in the breast biopsy marker space.
The market is expected to grow across the world as a result of technical developments occurring in breast biopsy markers. Due to the rising demand for breast biopsy markers, companies have eventfully boosted their R&D spending in an effort to provide new products.
Key players in the market are forming strategic alliances through mergers, capacity expansion, and other tactics to embrace technology and increase production capacity, specifically to meet the demands of the expanding healthcare sector.
Get Customization on Breast Biopsy Marker Market Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7619
Key players in the Breast Biopsy Marker Market
- Hologic
- Carbon Medical Technology
- BD
- Mermaid Medical
- Argon Medical Devices
- INRAD
- Cortex
- Cook Medical
- Scion Medical Technologies
Key Takeaways from Breast Biopsy Marker Market Study
- The global breast biopsy marker market is projected to expand at a CAGR of 5.8% and be valued at US$ 1.4 billion by 2032.
- The market exhibited 5.4% CAGR for the period of 2017-2021.
- Under material type, titanium dominates the market and is valued at US$ 186.5 million in 2022.
- South Asia and ASEAN dominated the market with 24.4% market share in 2021.
- Based on region, demand for breast biopsy markers is expected to increase at CAGRs of 5.2% and 6.4%, respectively, in South Asia and ASEAN and Europe.
Explore Fact.MR's Coverage on the Healthcare Domain-
Patient Engagement Solutions Market- The global patient engagement solutions market, the market is gaining traction steadily, rising at an 8.6% CAGR through 2032, exceeding a valuation of around US$ 29 Billion by 2022. As of the end of 2032, the market is expected to reach US$ 66.4 Billion.
Parenteral Nutrition Market - The industry is expected to reach US$ 7 Bn by 2022-end, experiencing Y-o-Y increase of 16% compared to 2021. From 2022-2032, the industry is forecast to increase 2x to reach US$ 14 Bn.
Medical Foods Market - The global sales of medical foods market garnered a market value of US$ 20 Bn in 2021, and is expected to register a CAGR of 5% by accumulating a market value of US$ 32.6 Bn through the forecast period 2022-2032.
Huntington’s Disease Treatment Market - The global Huntington’s disease treatment market was estimated to have a market size worth US$ 360 Mn in 2021 and is expected to grow at a CAGR of 20% from 2022-2032. The market is estimated to reach US$ 2.7 Bn by the end of 2032.
Drug Discovery Services Market- The drug discovery services market is forecasted to reach US$ 50 Billion by 2032, up from US$ 19 Billion in 2022, at a CAGR of 10.1%. A Y-o-Y growth rate of nearly 12% is expected for the market in 2022. As of 2021, the market was valued at US$ 17 Billion.
Lab Automation Market- Demand for lab automation services experienced a Y-o-Y expansion rate of over 11% in 2022 compared to 2021, rising from US$ 1.8 Billion to US$ 2 Billion. Going forward, the market is poised to flourish at a 7% value CAGR from 2022-2032, reaching a valuation of nearly US$ 4 Billion.
Smart Implants Market- The global smart implants market is estimated at US$ 3.9 billion in 2022, and is forecast to surpass a market value of US$ 22.2 billion by 2032. Smart implants are expected to contribute significantly to the global implants market, with demand surging at a CAGR of 19% from 2022 to 2032.
Facial Implants Market- The global facial implant market was valued at US$ 2.7 Billion in 2022, and is expected to rise at a 7.7% value CAGR, likely to reach US$ 5.6 Billion by the end of the 2022-2032 forecast period.
Electronic Health Records Market - The electronic health records market is expected to garner a market value of US$ 26.78 Bn in 2022, anticipated to register a positive CAGR of 4.5% in the forecast period 2022-2032 and reach a value of US$ 41.8 Bn.
Cardiac Resynchronization Therapy Market - CRT-Defibrillator is expected to be the higher revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 4 Bn during 2022 – 2032.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter
